Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
pharmaand GmbH
M.D. Anderson Cancer Center
pharmaand GmbH
H. Lee Moffitt Cancer Center and Research Institute
Peter MacCallum Cancer Centre, Australia
Dana-Farber Cancer Institute
Novartis
Novartis
Novartis
Mayo Clinic
Case Comprehensive Cancer Center
Novartis
M.D. Anderson Cancer Center
Emory University
Icahn School of Medicine at Mount Sinai
Novartis
Oncotherapeutics
City of Hope Medical Center